News archive search
Search the Newsreel
Search stored headlines and summaries, then narrow the results by company, country, sector, industry, source or date.
- Showing
- 37–43
- Matches
- 43
- Sources here
- 5
- Companies here
- 2
Search results
Stored financial headlines
Active search
43 matching headlines
Ticker or company: AVEXMain company stories
Search results
Matching headlines
External headlines link to their original source. Market context comes from stored weekly company data, not from an opinion about the article.
Anavex Life Sciences Corp (AVXL) Dividends & Stock Splits: Historical Payouts and Event Timeline
This article provides an overview of Anavex Life Sciences Corp (AVXL) regarding its dividend history and stock splits. It indicates that the company has not distributed any dividends over the past five years. The page also presents current stock performance data, market capitalization, and …
AVXL
main company
Sharemaestro market context
Price below Trend Line
52 weeks -66.2% · Next-week setup negative 44.9%
AVXL|Anavex Life Sciences Corp|Price:2.400|Chg%:-0.080
Anavex Life Sciences Corp. (AVXL) is a clinical-stage biopharmaceutical company focused on developing therapies for central nervous system diseases. The article provides an overview of the company's profile, including its core programs ANAVEX 2-73 and ANAVEX 3-71, and lists key executives and institutional shareholding …
AVXL
main company
Sharemaestro market context
Price below Trend Line
52 weeks -66.2% · Next-week setup negative 44.9%
Anavex Life Sciences Corp. Revenue Breakdown – SWB:12X1
This page provides financial information for Anavex Life Sciences Corp. (SWB:12X1) listed on the Stuttgart Stock Exchange. It offers an overview of the company's financials, including statements, statistics, dividends, earnings, and segment performance. The content is primarily a navigation hub to various financial data …
AVXL
main company
Sharemaestro market context
Price below Trend Line
52 weeks -66.2% · Next-week setup negative 44.9%
PVG targets full board replacement at Anavex Life Sciences (NASDAQ: AVXL)
PVG Asset Management Corporation and Patrick S. Adams are launching an activist proxy solicitation to replace the entire Board of Directors at Anavex Life Sciences (NASDAQ: AVXL) with six independent nominees during the 2026 annual meeting. The activist group, collectively owning 327,344 shares of …
AVXL
main company
Sharemaestro market context
Price below Trend Line
52 weeks -66.2% · Next-week setup negative 44.9%
Anavex Life Sciences submits compliance plan to Nasdaq after 10-Q delay
Anavex Life Sciences (AVXL) submitted a Compliance Plan to Nasdaq following a late Form 10-Q filing for the quarter ended March 31, 2026. The company aims to regain compliance with Nasdaq Rule 5250(c)(1) and seek reinstatement of its listing. While the deficiency notice does …
AVXL
main company
Sharemaestro market context
Price below Trend Line
52 weeks -66.2% · Next-week setup negative 44.9%